ADA do not appear to correlate with adverse reactions in either WD or CESD, however in WD, patients with ADA may show reduced response to treatment (Vijay et al., 2021), whereas this was not observed in CESD (Burton et al., 2015a; Burton et al., 2022). This evidence concerns the gene ADA and cholesteryl ester storage disease.